Section d4, lot number and expiration date were updated.Calibration and qc at the customer site was acceptable.The patient sample was submitted for investigation.The customer's result was reproduced with the elecsys anti-sars-cov-2 assay.Additional measurements determined this sample as positive with a rapid assay (weak igg) from creative diagnostics as well as an independent in-house roche assay detecting other antibodies against sars-cov-2.Given that the patient is regularly exposed to the common cold corona viruses (hku1, 229e, oc43 and nl63), an effective anti-corona-virus immune response might be in place, therefore differing from immune responses of naïve patients.As the determined coi-value for the investigated sample was slightly elevated after 30 days post positive pcr, a follow-up sample would be expected to result as positive.A general reagent issue can be excluded.The investigation did not identify a product problem.
|